{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:29:45Z","timestamp":1795008585138,"version":"4.9.1"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-024-02132-6","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:01:56Z","timestamp":1727503316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy"],"prefix":"10.1186","volume":"23","author":[{"given":"Jun-xiao","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-zan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-jie","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-fan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"key":"2132_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature. 2009;458:719\u201324. https:\/\/doi.org\/10.1038\/nature07943.","journal-title":"Nature"},{"key":"2132_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrg3317","volume":"13","author":"LR Yates","year":"2012","unstructured":"Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet. 2012;13:795\u2013806. https:\/\/doi.org\/10.1038\/nrg3317.","journal-title":"Nat Rev Genet"},{"key":"2132_CR3","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science (New York, NY). 2011;331:1565\u201370. https:\/\/doi.org\/10.1126\/science.1203486.","journal-title":"Science (New York, N.Y.)."},{"key":"2132_CR4","doi-asserted-by":"publisher","first-page":"0340023","DOI":"10.1088\/2057-1739\/aa7e86","volume":"3","author":"RJ Seager","year":"2017","unstructured":"Seager RJ, Hajal C, Spill F, Kamm RD, Zaman MH. Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression. Converg Sci Phys Oncol. 2017;3:0340023. https:\/\/doi.org\/10.1088\/2057-1739\/aa7e86.","journal-title":"Converg Sci Phys Oncol"},{"key":"2132_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"O Demaria","year":"2019","unstructured":"Demaria O, et al. Harnessing innate immunity in cancer therapy. Nature. 2019;574:45\u201356. https:\/\/doi.org\/10.1038\/s41586-019-1593-5.","journal-title":"Nature"},{"key":"2132_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-032414-112043","volume":"33","author":"SR Woo","year":"2015","unstructured":"Woo SR, Corrales L, Gajewski TF. Innate immune recognition of cancer. Annu Rev Immunol. 2015;33:445\u201374. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112043.","journal-title":"Annu Rev Immunol"},{"key":"2132_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature10755","volume":"482","author":"H Matsushita","year":"2012","unstructured":"Matsushita H, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature. 2012;482:400\u20134. https:\/\/doi.org\/10.1038\/nature10755.","journal-title":"Nature"},{"key":"2132_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","volume":"25","author":"GA Rabinovich","year":"2007","unstructured":"Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267\u201396. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141609.","journal-title":"Annu Rev Immunol"},{"key":"2132_CR9","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.Cd-18-0367","volume":"8","author":"SC Wei","year":"2018","unstructured":"Wei SC, Duffy CR, Allison JP. Fundamental Mechanisms of Immune Checkpoint Blockade Therapy. Cancer Discov. 2018;8:1069\u201386. https:\/\/doi.org\/10.1158\/2159-8290.Cd-18-0367.","journal-title":"Cancer Discov"},{"key":"2132_CR10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41573-020-0074-8","volume":"19","author":"A Harari","year":"2020","unstructured":"Harari A, Graciotti M, Bassani-Sternberg M, Kandalaft LE. Antitumour dendritic cell vaccination in a priming and boosting approach. Nat Rev Drug Discovery. 2020;19:635\u201352. https:\/\/doi.org\/10.1038\/s41573-020-0074-8.","journal-title":"Nat Rev Drug Discovery"},{"key":"2132_CR11","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41571-021-00476-2","volume":"18","author":"DL Wagner","year":"2021","unstructured":"Wagner DL, et al. Immunogenicity of CAR T cells in cancer therapy. Nat Rev Clin Oncol. 2021;18:379\u201393. https:\/\/doi.org\/10.1038\/s41571-021-00476-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"2132_CR12","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41577-022-00680-w","volume":"22","author":"R Hernandez","year":"2022","unstructured":"Hernandez R, P\u00f5der J, LaPorte KM, Malek TR. Engineering IL-2 for immunotherapy of autoimmunity and cancer. Nat Rev Immunol. 2022;22:614\u201328. https:\/\/doi.org\/10.1038\/s41577-022-00680-w.","journal-title":"Nat Rev Immunol"},{"key":"2132_CR13","doi-asserted-by":"publisher","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","volume":"2","author":"A Haslam","year":"2019","unstructured":"Haslam A, Prasad V. Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs. JAMA Netw Open. 2019;2:e192535.\u00a0https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.2535.","journal-title":"JAMA Netw Open"},{"key":"2132_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nri3790","volume":"15","author":"LT Nguyen","year":"2015","unstructured":"Nguyen LT, Ohashi PS. Clinical blockade of PD1 and LAG3\u2013potential mechanisms of action. Nat Rev Immunol. 2015;15:45\u201356. https:\/\/doi.org\/10.1038\/nri3790.","journal-title":"Nat Rev Immunol"},{"key":"2132_CR15","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang X, et al. Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11. Cancer Discov. 2019;9:1673\u201385. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0338.","journal-title":"Cancer Discov"},{"key":"2132_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang W, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1170-y.","journal-title":"Nature"},{"key":"2132_CR17","doi-asserted-by":"publisher","first-page":"676142","DOI":"10.3389\/fcell.2021.676142","volume":"9","author":"S Wang","year":"2021","unstructured":"Wang S, et al. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma. Frontiers in cell and developmental biology. 2021;9:676142.\u00a0https:\/\/doi.org\/10.3389\/fcell.2021.676142.","journal-title":"Frontiers in cell and developmental biology"},{"key":"2132_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"key":"2132_CR19","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, et al. Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature. 2012;485:201\u20136. https:\/\/doi.org\/10.1038\/nature11112.","journal-title":"Nature"},{"key":"2132_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","volume":"149","author":"KD Meyer","year":"2012","unstructured":"Meyer KD, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2019 UTRs and near stop codons. Cell. 2012;149:1635\u201346. https:\/\/doi.org\/10.1016\/j.cell.2012.05.003.","journal-title":"Cell"},{"key":"2132_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12943-023-01810-1","volume":"22","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. Epigenetic modification of m(6)A regulator proteins in cancer. Mol Cancer. 2023;22:102. https:\/\/doi.org\/10.1186\/s12943-023-01810-1.","journal-title":"Mol Cancer"},{"key":"2132_CR22","doi-asserted-by":"publisher","first-page":"132728","DOI":"10.1016\/j.ijbiomac.2024.132728","volume":"272","author":"M Chao","year":"2024","unstructured":"Chao M, et al. Profiling of m(6)A methylation in porcine intramuscular adipocytes and unravelling PHKG1 represses porcine intramuscular lipid deposition in an m(6)A-dependent manner. Int J Biol Macromol. 2024;272:132728.","journal-title":"Int J Biol Macromol"},{"key":"2132_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41368-024-00303-1","volume":"16","author":"Y Jin","year":"2024","unstructured":"Jin Y, Han X, Wang Y, Fan Z. METTL7A-mediated m6A modification of corin reverses bisphosphonates-impaired osteogenic differentiation of orofacial BMSCs. Int J Oral Sci. 2024;16:42. https:\/\/doi.org\/10.1038\/s41368-024-00303-1.","journal-title":"Int J Oral Sci"},{"key":"2132_CR24","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1038\/s41467-024-48730-2","volume":"15","author":"F Guo","year":"2024","unstructured":"Guo F, et al. Astrocytic ALKBH5 in stress response contributes to depressive-like behaviors in mice. Nat Commun. 2024;15:4347. https:\/\/doi.org\/10.1038\/s41467-024-48730-2.","journal-title":"Nat Commun"},{"key":"2132_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13059-024-03332-5","volume":"25","author":"Q Ma","year":"2024","unstructured":"Ma Q, et al. N6-methyladenosine writer METTL16-mediated alternative splicing and translation control are essential for murine spermatogenesis. Genome Biol. 2024;25:193. https:\/\/doi.org\/10.1186\/s13059-024-03332-5.","journal-title":"Genome Biol"},{"key":"2132_CR26","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/s44318-024-00082-9","volume":"43","author":"Y Han","year":"2024","unstructured":"Han Y, et al. A Mettl16\/m(6)A\/mybl2b\/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cells. EMBO J. 2024;43:1990\u20132014. https:\/\/doi.org\/10.1038\/s44318-024-00082-9.","journal-title":"EMBO J"},{"key":"2132_CR27","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nm.4091","volume":"22","author":"TG Bivona","year":"2016","unstructured":"Bivona TG, Doebele RC. A framework for understanding and targeting residual disease in oncogene-driven solid cancers. Nat Med. 2016;22:472\u20138. https:\/\/doi.org\/10.1038\/nm.4091.","journal-title":"Nat Med"},{"key":"2132_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 2015;523:231\u20135. https:\/\/doi.org\/10.1038\/nature14404.","journal-title":"Nature"},{"key":"2132_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.canlet.2021.10.034","volume":"525","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, et al. Wnt signaling pathway in cancer immunotherapy. Cancer Lett. 2022;525:84\u201396. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.034.","journal-title":"Cancer Lett"},{"key":"2132_CR30","doi-asserted-by":"publisher","first-page":"817112","DOI":"10.3389\/fcell.2022.817112","volume":"10","author":"F Tang","year":"2022","unstructured":"Tang F, Chen L, Gao H, Xiao D, Li X. m(6)A: An Emerging Role in Programmed Cell Death. Frontiers in cell and developmental biology. 2022;10:817112.","journal-title":"Frontiers in cell and developmental biology"},{"key":"2132_CR31","doi-asserted-by":"publisher","first-page":"982606","DOI":"10.3389\/fcell.2022.982606","volume":"10","author":"JCT Cheung","year":"2022","unstructured":"Cheung JCT, Deng G, Wong N, Dong Y, Ng SSM. More than a duologue: In-depth insights into epitranscriptomics and ferroptosis. Frontiers in cell and developmental biology. 2022;10:982606.\u00a0https:\/\/doi.org\/10.3389\/fcell.2022.982606.","journal-title":"Frontiers in cell and developmental biology"},{"key":"2132_CR32","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41580-022-00564-w","volume":"24","author":"P Vandenabeele","year":"2023","unstructured":"Vandenabeele P, Bultynck G, Savvides SN. Pore-forming proteins as drivers of membrane permeabilization in cell death pathways. Nat Rev Mol Cell Biol. 2023;24:312\u201333. https:\/\/doi.org\/10.1038\/s41580-022-00564-w.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2132_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00689-6","author":"J Yuan","year":"2023","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2023. https:\/\/doi.org\/10.1038\/s41580-023-00689-6.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2132_CR34","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma S, Lessnick SL, Hahn WC, Stockwell BR. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 2003;3:285\u201396. https:\/\/doi.org\/10.1016\/s1535-6108(03)00050-3.","journal-title":"Cancer Cell"},{"key":"2132_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/JEnvironPatholToxicolOncol.2023049084","volume":"43","author":"Z Wang","year":"2024","unstructured":"Wang Z, Yao X, Wang K, Wang B. TFR1-mediated iron metabolism orchestrates tumor ferroptosis and immunity in non-small cell lung cancer. Journal of environmental pathology, toxicology and oncology\u202f: official organ of the International Society for Environmental Toxicology and Cancer. 2024;43:1\u201312. https:\/\/doi.org\/10.1615\/JEnvironPatholToxicolOncol.2023049084.","journal-title":"Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer"},{"key":"2132_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0304-4157(96)00014-7","volume":"1331","author":"DR Richardson","year":"1997","unstructured":"Richardson DR, Ponka P. The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochem Biophys Acta. 1997;1331:1\u201340. https:\/\/doi.org\/10.1016\/s0304-4157(96)00014-7.","journal-title":"Biochem Biophys Acta"},{"key":"2132_CR37","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","volume":"30","author":"H Feng","year":"2020","unstructured":"Feng H, et al. Transferrin Receptor Is a Specific Ferroptosis Marker. Cell Rep. 2020;30:3411-3423.e3417. https:\/\/doi.org\/10.1016\/j.celrep.2020.02.049.","journal-title":"Cell Rep"},{"key":"2132_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.semcancer.2018.07.009","volume":"53","author":"M El Hout","year":"2018","unstructured":"El Hout M, Dos Santos L, Hama\u00ef A, Mehrpour M. A promising new approach to cancer therapy: Targeting iron metabolism in cancer stem cells. Semin Cancer Biol. 2018;53:125\u201338. https:\/\/doi.org\/10.1016\/j.semcancer.2018.07.009.","journal-title":"Semin Cancer Biol"},{"key":"2132_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, et al. Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell. 2017;171:273\u201385. https:\/\/doi.org\/10.1016\/j.cell.2017.09.021.","journal-title":"Cell"},{"key":"2132_CR40","doi-asserted-by":"publisher","first-page":"11491","DOI":"10.18632\/aging.202841","volume":"13","author":"ZW Hu","year":"2021","unstructured":"Hu ZW, et al. Comprehensive analysis of ferritin subunits expression and positive correlations with tumor-associated macrophages and T regulatory cells infiltration in most solid tumors. Aging. 2021;13:11491\u2013506. https:\/\/doi.org\/10.18632\/aging.202841.","journal-title":"Aging."},{"key":"2132_CR41","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah R, Shchepinov MS, Pratt DA. Resolving the Role of Lipoxygenases in the Initiation and Execution of Ferroptosis. ACS Cent Sci. 2018;4:387\u201396. https:\/\/doi.org\/10.1021\/acscentsci.7b00589.","journal-title":"ACS Cent Sci"},{"key":"2132_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka O, et al. On the Mechanism of Cytoprotection by Ferrostatin-1 and Liproxstatin-1 and the Role of Lipid Peroxidation in Ferroptotic Cell Death. ACS Cent Sci. 2017;3:232\u201343. https:\/\/doi.org\/10.1021\/acscentsci.7b00028.","journal-title":"ACS Cent Sci"},{"key":"2132_CR43","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.cell.2017.09.044","volume":"171","author":"SE Wenzel","year":"2017","unstructured":"Wenzel SE, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell. 2017;171:628-641.e626. https:\/\/doi.org\/10.1016\/j.cell.2017.09.044.","journal-title":"Cell"},{"key":"2132_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chembiol.2020.03.015","volume":"27","author":"Y Zou","year":"2020","unstructured":"Zou Y, Schreiber SL. Progress in understanding ferroptosis and challenges in its targeting for therapeutic benefit. Cell Chem Biol. 2020;27:463\u201371. https:\/\/doi.org\/10.1016\/j.chembiol.2020.03.015.","journal-title":"Cell Chem Biol"},{"key":"2132_CR45","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/s41419-020-03118-0","volume":"11","author":"B Wiernicki","year":"2020","unstructured":"Wiernicki B, et al. Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis. Cell Death Dis. 2020;11:922. https:\/\/doi.org\/10.1038\/s41419-020-03118-0.","journal-title":"Cell Death Dis"},{"key":"2132_CR46","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan VE, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13:81\u201390. https:\/\/doi.org\/10.1038\/nchembio.2238.","journal-title":"Nat Chem Biol"},{"key":"2132_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll S, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91\u20138. https:\/\/doi.org\/10.1038\/nchembio.2239.","journal-title":"Nat Chem Biol"},{"key":"2132_CR48","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","volume":"10","author":"SJ Dixon","year":"2015","unstructured":"Dixon SJ, et al. Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death. ACS Chem Biol. 2015;10:1604\u20139. https:\/\/doi.org\/10.1021\/acschembio.5b00245.","journal-title":"ACS Chem Biol"},{"key":"2132_CR49","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0.","journal-title":"Nat Rev Cancer"},{"key":"2132_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1101\/gad.314674.118","volume":"32","author":"M Conrad","year":"2018","unstructured":"Conrad M, et al. Regulation of lipid peroxidation and ferroptosis in diverse species. Genes Dev. 2018;32:602\u201319. https:\/\/doi.org\/10.1101\/gad.314674.118.","journal-title":"Genes Dev"},{"key":"2132_CR51","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16:302\u20139. https:\/\/doi.org\/10.1038\/s41589-020-0472-6.","journal-title":"Nat Chem Biol"},{"key":"2132_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-pathol-012513-104651","volume":"9","author":"JD Lambeth","year":"2014","unstructured":"Lambeth JD, Neish AS. Nox enzymes and new thinking on reactive oxygen: a double-edged sword revisited. Annu Rev Pathol. 2014;9:119\u201345. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104651.","journal-title":"Annu Rev Pathol"},{"key":"2132_CR53","doi-asserted-by":"publisher","first-page":"3644","DOI":"10.1038\/s41467-021-23902-6","volume":"12","author":"D Chen","year":"2021","unstructured":"Chen D, et al. iPLA2\u03b2-mediated lipid detoxification controls p53-driven ferroptosis independent of GPX4. Nat Commun. 2021;12:3644. https:\/\/doi.org\/10.1038\/s41467-021-23902-6.","journal-title":"Nat Commun"},{"key":"2132_CR54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature. 2020;585:603\u20138. https:\/\/doi.org\/10.1038\/s41586-020-2732-8.","journal-title":"Nature"},{"key":"2132_CR55","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery. 2013;12:931\u201347. https:\/\/doi.org\/10.1038\/nrd4002.","journal-title":"Nat Rev Drug Discovery"},{"key":"2132_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","volume":"42","author":"M Conrad","year":"2012","unstructured":"Conrad M, Sato H. The oxidative stress-inducible cystine\/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids. 2012;42:231\u201346. https:\/\/doi.org\/10.1007\/s00726-011-0867-5.","journal-title":"Amino Acids"},{"key":"2132_CR57","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell. 2014;156:317\u201331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010.","journal-title":"Cell"},{"key":"2132_CR58","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1158\/0008-5472.Can-18-3037","volume":"79","author":"T Liu","year":"2019","unstructured":"Liu T, Jiang L, Tavana O, Gu W. The Deubiquitylase OTUB1 Mediates Ferroptosis via Stabilization of SLC7A11. Can Res. 2019;79:1913\u201324. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-3037.","journal-title":"Can Res"},{"key":"2132_CR59","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death Differ. 2020;27:662\u201375. https:\/\/doi.org\/10.1038\/s41418-019-0380-z.","journal-title":"Cell Death Differ"},{"key":"2132_CR60","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","volume":"20","author":"Y Xie","year":"2017","unstructured":"Xie Y, et al. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Rep. 2017;20:1692\u2013704. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.055.","journal-title":"Cell Rep"},{"key":"2132_CR61","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan Z, et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis. 2017;6:e371. https:\/\/doi.org\/10.1038\/oncsis.2017.65.","journal-title":"Oncogenesis"},{"key":"2132_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD. NRF2 and the Hallmarks of Cancer. Cancer Cell. 2018;34:21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022.","journal-title":"Cancer Cell"},{"key":"2132_CR63","doi-asserted-by":"publisher","first-page":"E6806","DOI":"10.1073\/pnas.1607152113","volume":"113","author":"Y Ou","year":"2016","unstructured":"Ou Y, Wang SJ, Li D, Chu B, Gu W. Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci USA. 2016;113:E6806-e6812. https:\/\/doi.org\/10.1073\/pnas.1607152113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2132_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","volume":"38","author":"P Koppula","year":"2018","unstructured":"Koppula P, Zhang Y, Zhuang L, Gan B. Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer communications (London, England). 2018;38:12. https:\/\/doi.org\/10.1186\/s40880-018-0288-x.","journal-title":"Cancer communications (London, England)."},{"key":"2132_CR65","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12:599\u2013620. https:\/\/doi.org\/10.1007\/s13238-020-00789-5.","journal-title":"Protein Cell"},{"key":"2132_CR66","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1172\/jci124049","volume":"130","author":"K Hu","year":"2020","unstructured":"Hu K, et al. Suppression of the SLC7A11\/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma. J Clin Investig. 2020;130:1752\u201366. https:\/\/doi.org\/10.1172\/jci124049.","journal-title":"J Clin Investig"},{"key":"2132_CR67","doi-asserted-by":"publisher","first-page":"874","DOI":"10.2741\/2109","volume":"12","author":"JD McGivan","year":"2007","unstructured":"McGivan JD, Bungard CI. The transport of glutamine into mammalian cells. Front Biosci. 2007;12:874\u201382. https:\/\/doi.org\/10.2741\/2109.","journal-title":"Front Biosci"},{"key":"2132_CR68","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.cmet.2020.12.007","volume":"33","author":"YP Kang","year":"2021","unstructured":"Kang YP, et al. Non-canonical Glutamate-Cysteine Ligase Activity Protects against Ferroptosis. Cell Metab. 2021;33:174-189 e177. https:\/\/doi.org\/10.1016\/j.cmet.2020.12.007.","journal-title":"Cell Metab."},{"key":"2132_CR69","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250.","journal-title":"Cancer Commun (Lond)"},{"key":"2132_CR70","doi-asserted-by":"publisher","first-page":"102999","DOI":"10.1016\/j.redox.2023.102999","volume":"69","author":"C Xia","year":"2024","unstructured":"Xia C, et al. Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis. Redox Biol. 2024;69:102999.\u00a0https:\/\/doi.org\/10.1016\/j.redox.2023.102999.","journal-title":"Redox Biol"},{"key":"2132_CR71","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature. 2019;575:693\u20138. https:\/\/doi.org\/10.1038\/s41586-019-1707-0.","journal-title":"Nature"},{"key":"2132_CR72","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature. 2019;575:688\u201392. https:\/\/doi.org\/10.1038\/s41586-019-1705-2.","journal-title":"Nature"},{"key":"2132_CR73","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and Transferrin Regulate Ferroptosis. Mol Cell. 2015;59:298\u2013308. https:\/\/doi.org\/10.1016\/j.molcel.2015.06.011.","journal-title":"Mol Cell"},{"key":"2132_CR74","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao M, et al. Role of Mitochondria in Ferroptosis. Mol Cell. 2019;73:354-363.e353. https:\/\/doi.org\/10.1016\/j.molcel.2018.10.042.","journal-title":"Mol Cell"},{"issue":"6","key":"2132_CR75","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cells9061505","volume":"9","author":"AM Battaglia","year":"2020","unstructured":"Battaglia AM, et al. Ferroptosis and Cancer: Mitochondria Meet the \u201cIron Maiden\u201d Cell Death. Cells. 2020;9(6):1505. https:\/\/doi.org\/10.3390\/cells9061505.","journal-title":"Cells."},{"key":"2132_CR76","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1038\/s41416-024-02670-2","volume":"130","author":"Z Wang","year":"2024","unstructured":"Wang Z, et al. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma. Br J Cancer. 2024;130:1744\u201357. https:\/\/doi.org\/10.1038\/s41416-024-02670-2.","journal-title":"Br J Cancer"},{"key":"2132_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature04512","volume":"440","author":"GC Shaw","year":"2006","unstructured":"Shaw GC, et al. Mitoferrin is essential for erythroid iron assimilation. Nature. 2006;440:96\u2013100. https:\/\/doi.org\/10.1038\/nature04512.","journal-title":"Nature"},{"key":"2132_CR78","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/mcb.01685-08","volume":"29","author":"PN Paradkar","year":"2009","unstructured":"Paradkar PN, Zumbrennen KB, Paw BH, Ward DM, Kaplan J. Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2. Mol Cell Biol. 2009;29:1007\u201316. https:\/\/doi.org\/10.1128\/mcb.01685-08.","journal-title":"Mol Cell Biol"},{"key":"2132_CR79","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.bbamcr.2014.10.014","volume":"1853","author":"S Tamir","year":"2015","unstructured":"Tamir S, et al. Structure-function analysis of NEET proteins uncovers their role as key regulators of iron and ROS homeostasis in health and disease. Biochem Biophys Acta. 2015;1853:1294\u2013315. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.10.014.","journal-title":"Biochem Biophys Acta"},{"key":"2132_CR80","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbrc.2016.08.034","volume":"478","author":"H Yuan","year":"2016","unstructured":"Yuan H, Li X, Zhang X, Kang R, Tang D. CISD1 inhibits ferroptosis by protection against mitochondrial lipid peroxidation. Biochem Biophys Res Commun. 2016;478:838\u201344. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.034.","journal-title":"Biochem Biophys Res Commun"},{"key":"2132_CR81","doi-asserted-by":"publisher","first-page":"101670","DOI":"10.1016\/j.redox.2020.101670","volume":"36","author":"DC Fuhrmann","year":"2020","unstructured":"Fuhrmann DC, Mondorf A, Beifu\u00df J, Jung M, Br\u00fcne B. Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol. 2020;36:101670.\u00a0https:\/\/doi.org\/10.1016\/j.redox.2020.101670.","journal-title":"Redox Biol"},{"key":"2132_CR82","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fnagi.2016.00308","volume":"8","author":"YQ Wang","year":"2016","unstructured":"Wang YQ, et al. The protective role of mitochondrial ferritin on erastin-induced ferroptosis. Front Aging Neurosci. 2016;8:308. https:\/\/doi.org\/10.3389\/fnagi.2016.00308.","journal-title":"Front Aging Neurosci"},{"key":"2132_CR83","doi-asserted-by":"publisher","first-page":"4152","DOI":"10.1073\/pnas.1119338109","volume":"109","author":"Y Ichikawa","year":"2012","unstructured":"Ichikawa Y, et al. Disruption of ATP-binding cassette B8 in mice leads to cardiomyopathy through a decrease in mitochondrial iron export. Proc Natl Acad Sci USA. 2012;109:4152\u20137. https:\/\/doi.org\/10.1073\/pnas.1119338109.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2132_CR84","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez R, Schreiber SL, Conrad M. Persister cancer cells: Iron addiction and vulnerability to ferroptosis. Mol Cell. 2022;82:728\u201340. https:\/\/doi.org\/10.1016\/j.molcel.2021.12.001.","journal-title":"Mol Cell"},{"key":"2132_CR85","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41589-019-0462-8","volume":"16","author":"AA Kapralov","year":"2020","unstructured":"Kapralov AA, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nat Chem Biol. 2020;16:278\u201390. https:\/\/doi.org\/10.1038\/s41589-019-0462-8.","journal-title":"Nat Chem Biol"},{"key":"2132_CR86","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu C, et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 2021;35:109235.\u00a0https:\/\/doi.org\/10.1016\/j.celrep.2021.109235.","journal-title":"Cell Rep"},{"key":"2132_CR87","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu S, et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors. Immunity. 2021;54:1561-1577.e1567. https:\/\/doi.org\/10.1016\/j.immuni.2021.05.003.","journal-title":"Immunity"},{"key":"2132_CR88","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","volume":"33","author":"SM Poznanski","year":"2021","unstructured":"Poznanski SM, et al. Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment. Cell Metab. 2021;33:1205-1220.e1205. https:\/\/doi.org\/10.1016\/j.cmet.2021.03.023.","journal-title":"Cell Metab"},{"key":"2132_CR89","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/s41419-020-2618-6","volume":"11","author":"DH Kim","year":"2020","unstructured":"Kim DH, Kim WD, Kim SK, Moon DH, Lee SJ. TGF-\u03b21-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells. Cell Death Dis. 2020;11:406. https:\/\/doi.org\/10.1038\/s41419-020-2618-6.","journal-title":"Cell Death Dis"},{"issue":"7","key":"2132_CR90","doi-asserted-by":"publisher","first-page":"e47563","DOI":"10.15252\/embr.201847563","volume":"20","author":"Y Wang","year":"2019","unstructured":"Wang Y, et al. Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53. EMBO Rep. 2019;20(7):e47563. https:\/\/doi.org\/10.15252\/embr.201847563.","journal-title":"EMBO Rep"},{"key":"2132_CR91","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","volume":"21","author":"B Chu","year":"2019","unstructured":"Chu B, et al. ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nat Cell Biol. 2019;21:579\u201391. https:\/\/doi.org\/10.1038\/s41556-019-0305-6.","journal-title":"Nat Cell Biol"},{"key":"2132_CR92","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/sj.onc.1201861","volume":"16","author":"DE Jensen","year":"1998","unstructured":"Jensen DE, et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene. 1998;16:1097\u2013112. https:\/\/doi.org\/10.1038\/sj.onc.1201861.","journal-title":"Oncogene"},{"key":"2132_CR93","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20:1181\u201392. https:\/\/doi.org\/10.1038\/s41556-018-0178-0.","journal-title":"Nat Cell Biol"},{"key":"2132_CR94","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature11404","volume":"489","author":"Comprehensive genomic characterization of squamous cell lung cancers","year":"2012","unstructured":"Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519\u201325. https:\/\/doi.org\/10.1038\/nature11404.","journal-title":"Nature"},{"key":"2132_CR95","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jtho.2022.03.011","volume":"17","author":"S Scalera","year":"2022","unstructured":"Scalera S, et al. KEAP1-Mutant NSCLC: The catastrophic failure of a cell-protecting hub. J Thor Oncol\u202f: official publication of the International Association for the Study of Lung Cancer. 2022;17:751\u20137. https:\/\/doi.org\/10.1016\/j.jtho.2022.03.011.","journal-title":"J Thor Oncol : official publication of the International Association for the Study of Lung Cancer"},{"key":"2132_CR96","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula P, et al. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat Commun. 2022;13:2206. https:\/\/doi.org\/10.1038\/s41467-022-29905-1.","journal-title":"Nat Commun"},{"key":"2132_CR97","doi-asserted-by":"publisher","first-page":"eabj9141","DOI":"10.1126\/sciadv.abj9141","volume":"7","author":"S Egolf","year":"2021","unstructured":"Egolf S, et al. MLL4 mediates differentiation and tumor suppression through ferroptosis. Sci Adv. 2021;7:eabj9141. https:\/\/doi.org\/10.1126\/sciadv.abj9141.","journal-title":"Sci Adv."},{"key":"2132_CR98","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1038\/s41467-020-20154-8","volume":"11","author":"E Dai","year":"2020","unstructured":"Dai E, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173\/STING-dependent DNA sensor pathway. Nat Commun. 2020;11:6339. https:\/\/doi.org\/10.1038\/s41467-020-20154-8.","journal-title":"Nat Commun"},{"key":"2132_CR99","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1038\/s41423-020-0456-1","volume":"18","author":"C Fang","year":"2021","unstructured":"Fang C, et al. Oxidized mitochondrial DNA sensing by STING signaling promotes the antitumor effect of an irradiated immunogenic cancer cell vaccine. Cell Mol Immunol. 2021;18:2211\u201323. https:\/\/doi.org\/10.1038\/s41423-020-0456-1.","journal-title":"Cell Mol Immunol"},{"key":"2132_CR100","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nature reviews Cancer. 2019;19:405\u201314. https:\/\/doi.org\/10.1038\/s41568-019-0149-1.","journal-title":"Nature reviews. Cancer."},{"key":"2132_CR101","doi-asserted-by":"publisher","first-page":"595498","DOI":"10.3389\/fphar.2020.595498","volume":"11","author":"AM Johnson","year":"2020","unstructured":"Johnson AM, Kleczko EK, Nemenoff RA. Eicosanoids in Cancer: New Roles in Immunoregulation. Front Pharmacol. 2020;11:595498.\u00a0https:\/\/doi.org\/10.3389\/fphar.2020.595498.","journal-title":"Front Pharmacol"},{"key":"2132_CR102","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/carcin\/bgv123","volume":"36","author":"D Wang","year":"2015","unstructured":"Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis. 2015;36:1085\u201393. https:\/\/doi.org\/10.1093\/carcin\/bgv123.","journal-title":"Carcinogenesis"},{"key":"2132_CR103","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature14034","volume":"517","author":"AV Kurtova","year":"2015","unstructured":"Kurtova AV, et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature. 2015;517:209\u201313. https:\/\/doi.org\/10.1038\/nature14034.","journal-title":"Nature"},{"key":"2132_CR104","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2015.02.002","volume":"42","author":"SE Weinberg","year":"2015","unstructured":"Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity. 2015;42:406\u201317. https:\/\/doi.org\/10.1016\/j.immuni.2015.02.002.","journal-title":"Immunity"},{"key":"2132_CR105","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1089\/ars.2012.4617","volume":"19","author":"X Lin","year":"2013","unstructured":"Lin X, et al. Oxidative stress in malignant melanoma enhances tumor necrosis factor-\u03b1 secretion of tumor-associated macrophages that promote cancer cell invasion. Antioxid Redox Signal. 2013;19:1337\u201355. https:\/\/doi.org\/10.1089\/ars.2012.4617.","journal-title":"Antioxid Redox Signal"},{"key":"2132_CR106","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13046-023-02629-w","volume":"42","author":"JX Cui","year":"2023","unstructured":"Cui JX, et al. L-kynurenine induces NK cell loss in gastric cancer microenvironment via promoting ferroptosis. J Exp Clin Cancer Res\u202f: CR. 2023;42:52. https:\/\/doi.org\/10.1186\/s13046-023-02629-w.","journal-title":"J Exp Clin Cancer Res : CR"},{"key":"2132_CR107","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/nm.2172","volume":"16","author":"DL Herber","year":"2010","unstructured":"Herber DL, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nat Med. 2010;16:880\u20136. https:\/\/doi.org\/10.1038\/nm.2172.","journal-title":"Nat Med"},{"key":"2132_CR108","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.cell.2015.05.025","volume":"161","author":"JR Cubillos-Ruiz","year":"2015","unstructured":"Cubillos-Ruiz JR, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161:1527\u201338. https:\/\/doi.org\/10.1016\/j.cell.2015.05.025.","journal-title":"Cell"},{"key":"2132_CR109","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bbrc.2021.08.082","volume":"576","author":"L Han","year":"2021","unstructured":"Han L, et al. PPARG-mediated ferroptosis in dendritic cells limits antitumor immunity. Biochem Biophys Res Commun. 2021;576:33\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.082.","journal-title":"Biochem Biophys Res Commun"},{"key":"2132_CR110","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","volume":"33","author":"X Ma","year":"2021","unstructured":"Ma X, et al. CD36-mediated ferroptosis dampens intratumoral CD8(+) T cell effector function and impairs their antitumor ability. Cell Metab. 2021;33:1001-1012.e1005. https:\/\/doi.org\/10.1016\/j.cmet.2021.02.015.","journal-title":"Cell Metab"},{"issue":"7","key":"2132_CR111","doi-asserted-by":"publisher","first-page":"e153247","DOI":"10.1172\/jci153247","volume":"132","author":"L Xiao","year":"2022","unstructured":"Xiao L, et al. IL-9\/STAT3\/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity. J Clin Invest. 2022;132(7):e153247.","journal-title":"J Clin Invest."},{"key":"2132_CR112","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41590-021-00996-0","volume":"22","author":"Y Yao","year":"2021","unstructured":"Yao Y, et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat Immunol. 2021;22:1127\u201339. https:\/\/doi.org\/10.1038\/s41590-021-00996-0.","journal-title":"Nat Immunol"},{"key":"2132_CR113","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1136\/gutjnl-2022-327909","volume":"72","author":"C Conche","year":"2023","unstructured":"Conche C, et al. Combining ferroptosis induction with MDSC blockade renders primary tumours and metastases in liver sensitive to immune checkpoint blockade. Gut. 2023;72:1774\u201382. https:\/\/doi.org\/10.1136\/gutjnl-2022-327909.","journal-title":"Gut"},{"key":"2132_CR114","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.\u00a0https:\/\/doi.org\/10.1016\/j.redox.2022.102463.","journal-title":"Redox Biol"},{"issue":"2","key":"2132_CR115","doi-asserted-by":"publisher","first-page":"e2203973","DOI":"10.1002\/advs.202203973","volume":"10","author":"B Tang","year":"2023","unstructured":"Tang B, et al. Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against HCC and enhances the efficacy of the anti-PD-1\/L1 response. Advanced Sci (Weinheim, Baden-Wurttemberg, Germany). 2023;10(2):e2203973. https:\/\/doi.org\/10.1002\/advs.202203973.","journal-title":"Advanced Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"2132_CR116","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.omtn.2019.11.022","volume":"19","author":"W Zhao","year":"2020","unstructured":"Zhao W, et al. Epigenetic regulation of m(6)A modifications in human cancer. Mol Ther Nucleic Acids. 2020;19:405\u201312. https:\/\/doi.org\/10.1016\/j.omtn.2019.11.022.","journal-title":"Mol Ther Nucleic Acids"},{"key":"2132_CR117","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","volume":"37","author":"H Huang","year":"2020","unstructured":"Huang H, Weng H, Chen J. m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer. Cancer Cell. 2020;37:270\u201388. https:\/\/doi.org\/10.1016\/j.ccell.2020.02.004.","journal-title":"Cancer Cell"},{"key":"2132_CR118","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","volume":"16","author":"X Wang","year":"2020","unstructured":"Wang X, et al. m(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7. Autophagy. 2020;16:1221\u201335. https:\/\/doi.org\/10.1080\/15548627.2019.1659617.","journal-title":"Autophagy"},{"key":"2132_CR119","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","volume":"518","author":"W Xie","year":"2019","unstructured":"Xie W, Ma LL, Xu YQ, Wang BH, Li SM. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism. Biochem Biophys Res Commun. 2019;518:120\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2019.08.018.","journal-title":"Biochem Biophys Res Commun"},{"key":"2132_CR120","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1096\/fj.201801393RRR","volume":"33","author":"Q Jiang","year":"2019","unstructured":"Jiang Q, et al. MTCH2 promotes adipogenesis in intramuscular preadipocytes via an m(6)A-YTHDF1-dependent mechanism. FASEB journal\u202f: official publication of the Federation of American Societies for Experimental Biology. 2019;33:2971\u201381. https:\/\/doi.org\/10.1096\/fj.201801393RRR.","journal-title":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology"},{"key":"2132_CR121","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.gpb.2020.06.003","volume":"18","author":"Y Li","year":"2020","unstructured":"Li Y, et al. m(6)A regulates liver metabolic disorders and hepatogenous diabetes. Genom Proteom Bioinform. 2020;18:371\u201383. https:\/\/doi.org\/10.1016\/j.gpb.2020.06.003.","journal-title":"Genom Proteom Bioinform"},{"key":"2132_CR122","doi-asserted-by":"publisher","first-page":"783322","DOI":"10.3389\/fcell.2021.783322","volume":"9","author":"M Huang","year":"2021","unstructured":"Huang M, et al. m6A Methylation Regulates Osteoblastic Differentiation and Bone Remodeling. Frontiers in cell and developmental biology. 2021;9:783322.\u00a0https:\/\/doi.org\/10.3389\/fcell.2021.783322.","journal-title":"Frontiers in cell and developmental biology"},{"key":"2132_CR123","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1096\/fj.201802644R","volume":"33","author":"Y Yao","year":"2019","unstructured":"Yao Y, et al. METTL3 inhibits BMSC adipogenic differentiation by targeting the JAK1\/STAT5\/C\/EBP\u03b2 pathway via an m(6)A-YTHDF2-dependent manner. FASEB J\u202f: official publication of the Federation of American Societies for Experimental Biology. 2019;33:7529\u201344. https:\/\/doi.org\/10.1096\/fj.201802644R.","journal-title":"FASEB J : official publication of the Federation of American Societies for Experimental Biology"},{"key":"2132_CR124","doi-asserted-by":"publisher","first-page":"111038","DOI":"10.1016\/j.cellsig.2024.111038","volume":"115","author":"ZW Feng","year":"2024","unstructured":"Feng ZW, et al. METTL3-mediated m(6)A modification of SOX4 regulates osteoblast proliferation and differentiation via YTHDF3 recognition. Cell Signal. 2024;115:111038.\u00a0https:\/\/doi.org\/10.1016\/j.cellsig.2024.111038.","journal-title":"Cell Signal"},{"key":"2132_CR125","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41422-018-0092-9","volume":"28","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, et al. METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation. Cell Res. 2018;28:1050\u201361. https:\/\/doi.org\/10.1038\/s41422-018-0092-9.","journal-title":"Cell Res"},{"key":"2132_CR126","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1093\/hmg\/ddx128","volume":"26","author":"L Li","year":"2017","unstructured":"Li L, et al. Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Hum Mol Genet. 2017;26:2398\u2013411. https:\/\/doi.org\/10.1093\/hmg\/ddx128.","journal-title":"Hum Mol Genet"},{"key":"2132_CR127","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41586-018-0666-1","volume":"563","author":"H Shi","year":"2018","unstructured":"Shi H, et al. m(6)A facilitates hippocampus-dependent learning and memory through YTHDF1. Nature. 2018;563:249\u201353. https:\/\/doi.org\/10.1038\/s41586-018-0666-1.","journal-title":"Nature"},{"key":"2132_CR128","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuron.2019.12.013","volume":"105","author":"H Xu","year":"2020","unstructured":"Xu H, et al. m(6)A mRNA methylation is essential for oligodendrocyte maturation and CNS myelination. Neuron. 2020;105:293-309.e295. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.013.","journal-title":"Neuron"},{"key":"2132_CR129","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10565-021-09601-4","volume":"38","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Sevoflurane impairs m6A-mediated mRNA translation and leads to fine motor and cognitive deficits. Cell Biol Toxicol. 2022;38:347\u201369. https:\/\/doi.org\/10.1007\/s10565-021-09601-4.","journal-title":"Cell Biol Toxicol"},{"key":"2132_CR130","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.molcel.2017.08.003","volume":"67","author":"I Ivanova","year":"2017","unstructured":"Ivanova I, et al. The RNA m(6)A reader YTHDF2 is essential for the post-transcriptional regulation of the maternal transcriptome and oocyte competence. Mol Cell. 2017;67:1059-1067.e1054. https:\/\/doi.org\/10.1016\/j.molcel.2017.08.003.","journal-title":"Mol Cell"},{"key":"2132_CR131","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1038\/s41467-023-42302-6","volume":"14","author":"L Bai","year":"2023","unstructured":"Bai L, et al. ALKBH5 controls the meiosis-coupled mRNA clearance in oocytes by removing the N (6)-methyladenosine methylation. Nat Commun. 2023;14:6532. https:\/\/doi.org\/10.1038\/s41467-023-42302-6.","journal-title":"Nat Commun"},{"key":"2132_CR132","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.freeradbiomed.2024.05.048","volume":"222","author":"M Cao","year":"2024","unstructured":"Cao M, et al. METTL3 deficiency leads to ovarian insufficiency due to IL-1\u03b2 overexpression in theca cells. Free Radical Biol Med. 2024;222:72\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.05.048.","journal-title":"Free Radical Biol Med"},{"key":"2132_CR133","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00018-024-05119-0","volume":"81","author":"Z Li","year":"2024","unstructured":"Li Z, et al. RNA m(6)A modification regulates L1 retrotransposons in human spermatogonial stem cell differentiation in vitro and in vivo. Cellular and molecular life sciences\u202f: CMLS. 2024;81:92. https:\/\/doi.org\/10.1007\/s00018-024-05119-0.","journal-title":"Cellular and molecular life sciences : CMLS"},{"key":"2132_CR134","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nature23883","volume":"549","author":"C Zhang","year":"2017","unstructured":"Zhang C, et al. m(6)A modulates haematopoietic stem and progenitor cell specification. Nature. 2017;549:273\u20136. https:\/\/doi.org\/10.1038\/nature23883.","journal-title":"Nature"},{"key":"2132_CR135","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-019-1038-7","volume":"18","author":"T Li","year":"2019","unstructured":"Li T, et al. METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma. Mol Cancer. 2019;18:112. https:\/\/doi.org\/10.1186\/s12943-019-1038-7.","journal-title":"Mol Cancer"},{"key":"2132_CR136","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1158\/0008-5472.Can-18-2868","volume":"79","author":"F Li","year":"2019","unstructured":"Li F, et al. N(6)-Methyladenosine Modulates Nonsense-Mediated mRNA Decay in Human Glioblastoma. Can Res. 2019;79:5785\u201398. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2868.","journal-title":"Can Res"},{"key":"2132_CR137","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.1038\/s41388-020-1338-9","volume":"39","author":"T Sun","year":"2020","unstructured":"Sun T, et al. LNC942 promoting METTL14-mediated m(6)A methylation in breast cancer cell proliferation and progression. Oncogene. 2020;39:5358\u201372. https:\/\/doi.org\/10.1038\/s41388-020-1338-9.","journal-title":"Oncogene"},{"key":"2132_CR138","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/cac2.12075","volume":"40","author":"Y Xu","year":"2020","unstructured":"Xu Y, et al. The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Comm (London, England). 2020;40:484\u2013500. https:\/\/doi.org\/10.1002\/cac2.12075.","journal-title":"Cancer Comm (London, England)"},{"key":"2132_CR139","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.stem.2020.04.009","volume":"27","author":"C Shen","year":"2020","unstructured":"Shen C, et al. RNA Demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia. Cell Stem Cell. 2020;27:64-80.e69. https:\/\/doi.org\/10.1016\/j.stem.2020.04.009.","journal-title":"Cell Stem Cell"},{"key":"2132_CR140","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40364-023-00464-x","volume":"11","author":"R Li","year":"2023","unstructured":"Li R, et al. RNA demethylase ALKBH5 promotes tumorigenesis of t (8;21) acute myeloid leukemia via ITPA m6A modification. Biomarker Res. 2023;11:30. https:\/\/doi.org\/10.1186\/s40364-023-00464-x.","journal-title":"Biomarker Res"},{"key":"2132_CR141","doi-asserted-by":"publisher","first-page":"817584","DOI":"10.3389\/fonc.2022.817584","volume":"12","author":"Q Xiao","year":"2022","unstructured":"Xiao Q, et al. Mutant NPM1-Regulated FTO-Mediated m(6)A demethylation promotes leukemic cell survival via PDGFRB\/ERK signaling axis. Front Oncol. 2022;12:817584.","journal-title":"Front Oncol"},{"issue":"2","key":"2132_CR142","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.3390\/ijms24021624","volume":"24","author":"J Huang","year":"2023","unstructured":"Huang J, et al. Cytoplasmic expression of TP53INP2 modulated by demethylase FTO and mutant NPM1 promotes autophagy in leukemia cells. Int J Mol Sci. 2023;24(2):1624. https:\/\/doi.org\/10.3390\/ijms24021624.","journal-title":"Int J Mol Sci."},{"key":"2132_CR143","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, et al. m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun. 2019;10:2782. https:\/\/doi.org\/10.1038\/s41467-019-10669-0.","journal-title":"Nat Commun"},{"key":"2132_CR144","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41388-020-01638-9","volume":"40","author":"P Zhu","year":"2021","unstructured":"Zhu P, et al. A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability. Oncogene. 2021;40:1609\u201327. https:\/\/doi.org\/10.1038\/s41388-020-01638-9.","journal-title":"Oncogene."},{"key":"2132_CR145","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12943-023-01791-1","volume":"22","author":"H Fang","year":"2023","unstructured":"Fang H, et al. m(6)A methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023;22:99. https:\/\/doi.org\/10.1186\/s12943-023-01791-1.","journal-title":"Mol Cancer"},{"key":"2132_CR146","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1158\/0008-5472.Can-20-0066","volume":"81","author":"J Pi","year":"2021","unstructured":"Pi J, et al. YTHDF1 promotes gastric carcinogenesis by controlling translation of FZD7. Can Res. 2021;81:2651\u201365. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0066.","journal-title":"Can Res"},{"key":"2132_CR147","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41388-020-1303-7","volume":"39","author":"C Zhang","year":"2020","unstructured":"Zhang C, et al. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Oncogene. 2020;39:4507\u201318. https:\/\/doi.org\/10.1038\/s41388-020-1303-7.","journal-title":"Oncogene"},{"key":"2132_CR148","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12943-019-1082-3","volume":"18","author":"J Hou","year":"2019","unstructured":"Hou J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163. https:\/\/doi.org\/10.1186\/s12943-019-1082-3.","journal-title":"Mol Cancer"},{"key":"2132_CR149","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","volume":"18","author":"W Ni","year":"2019","unstructured":"Ni W, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol Cancer. 2019;18:143. https:\/\/doi.org\/10.1186\/s12943-019-1079-y.","journal-title":"Mol Cancer"},{"key":"2132_CR150","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40364-023-00495-4","volume":"11","author":"X Yang","year":"2023","unstructured":"Yang X, et al. EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p\/RNF113A pathway. Biomarker research. 2023;11:59. https:\/\/doi.org\/10.1186\/s40364-023-00495-4.","journal-title":"Biomarker research"},{"key":"2132_CR151","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2. Hepatology (Baltimore, Md). 2018;67:2254\u201370. https:\/\/doi.org\/10.1002\/hep.29683.","journal-title":"Hepatology (Baltimore, Md.)."},{"key":"2132_CR152","doi-asserted-by":"publisher","first-page":"e103181","DOI":"10.15252\/embj.2019103181","volume":"39","author":"Z Lin","year":"2020","unstructured":"Lin Z, et al. RNA m(6) A methylation regulates sorafenib resistance in liver cancer through FOXO3-mediated autophagy. EMBO J. 2020;39:e103181. https:\/\/doi.org\/10.15252\/embj.2019103181.","journal-title":"EMBO J"},{"key":"2132_CR153","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-020-01249-8","volume":"19","author":"M Wang","year":"2020","unstructured":"Wang M, et al. Upregulation of METTL14 mediates the elevation of PERP mRNA N(6) adenosine methylation promoting the growth and metastasis of pancreatic cancer. Mol Cancer. 2020;19:130. https:\/\/doi.org\/10.1186\/s12943-020-01249-8.","journal-title":"Mol Cancer"},{"key":"2132_CR154","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/j.gastro.2021.12.269","volume":"162","author":"S Wang","year":"2022","unstructured":"Wang S, et al. N6-Methyladenosine Reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer. Gastroenterology. 2022;162:1183\u201396. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.269.","journal-title":"Gastroenterology"},{"key":"2132_CR155","doi-asserted-by":"publisher","first-page":"7476","DOI":"10.18632\/oncotarget.23554","volume":"9","author":"Y Nishizawa","year":"2018","unstructured":"Nishizawa Y, et al. Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer. Oncotarget. 2018;9:7476\u201386. https:\/\/doi.org\/10.18632\/oncotarget.23554.","journal-title":"Oncotarget."},{"key":"2132_CR156","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1002\/1878-0261.12898","volume":"15","author":"D Zhou","year":"2021","unstructured":"Zhou D, et al. METTL3\/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5. Mol Oncol. 2021;15:2172\u201384. https:\/\/doi.org\/10.1002\/1878-0261.12898.","journal-title":"Mol Oncol"},{"key":"2132_CR157","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19:106. https:\/\/doi.org\/10.1186\/s12943-020-01220-7.","journal-title":"Mol Cancer"},{"key":"2132_CR158","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-020-1146-4","volume":"19","author":"X Yang","year":"2020","unstructured":"Yang X, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19:46. https:\/\/doi.org\/10.1186\/s12943-020-1146-4.","journal-title":"Mol Cancer"},{"key":"2132_CR159","doi-asserted-by":"publisher","first-page":"11838","DOI":"10.1021\/acsnano.3c03050","volume":"17","author":"S Wu","year":"2023","unstructured":"Wu S, et al. Therapeutic m(6)A Eraser ALKBH5 mRNA-Loaded Exosome-Liposome Hybrid Nanoparticles Inhibit Progression of Colorectal Cancer in Preclinical Tumor Models. ACS Nano. 2023;17:11838\u201354. https:\/\/doi.org\/10.1021\/acsnano.3c03050.","journal-title":"ACS Nano"},{"key":"2132_CR160","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3724\/abbs.2023002","volume":"55","author":"P Du","year":"2023","unstructured":"Du P, et al. The miR-27a-3p\/FTO axis modifies hypoxia-induced malignant behaviors of glioma cells. Acta Biochim Biophys Sin. 2023;55:103\u201316. https:\/\/doi.org\/10.3724\/abbs.2023002.","journal-title":"Acta Biochim Biophys Sin"},{"key":"2132_CR161","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.celrep.2017.02.059","volume":"18","author":"Q Cui","year":"2017","unstructured":"Cui Q, et al. m(6)A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells. Cell Rep. 2017;18:2622\u201334. https:\/\/doi.org\/10.1016\/j.celrep.2017.02.059.","journal-title":"Cell Rep"},{"key":"2132_CR162","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-020-01239-w","volume":"19","author":"Y Chen","year":"2020","unstructured":"Chen Y, et al. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m(6)A-guided epigenetic inhibition of LYPD1. Mol Cancer. 2020;19:123. https:\/\/doi.org\/10.1186\/s12943-020-01239-w.","journal-title":"Mol Cancer"},{"key":"2132_CR163","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/hep.31766","volume":"74","author":"T Su","year":"2021","unstructured":"Su T, et al. Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism. Hepatology (Baltimore, Md). 2021;74:1339\u201356. https:\/\/doi.org\/10.1002\/hep.31766.","journal-title":"Hepatology (Baltimore, Md)."},{"key":"2132_CR164","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1002\/hep.28885","volume":"65","author":"JZ Ma","year":"2017","unstructured":"Ma JZ, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology (Baltimore, Md). 2017;65:529\u201343. https:\/\/doi.org\/10.1002\/hep.28885.","journal-title":"Hepatology (Baltimore, Md.)."},{"key":"2132_CR165","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12943-020-01158-w","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, et al. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. Mol Cancer. 2020;19:91. https:\/\/doi.org\/10.1186\/s12943-020-01158-w.","journal-title":"Mol Cancer"},{"key":"2132_CR166","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-019-1128-6","volume":"19","author":"B Tang","year":"2020","unstructured":"Tang B, et al. m(6)A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Mol Cancer. 2020;19:3. https:\/\/doi.org\/10.1186\/s12943-019-1128-6.","journal-title":"Mol Cancer"},{"key":"2132_CR167","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12943-019-1088-x","volume":"18","author":"R Jia","year":"2019","unstructured":"Jia R, et al. m(6)A modification suppresses ocular melanoma through modulating HINT2 mRNA translation. Mol Cancer. 2019;18:161. https:\/\/doi.org\/10.1186\/s12943-019-1088-x.","journal-title":"Mol Cancer"},{"key":"2132_CR168","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, et al. m(6)A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. Cancer Cell. 2017;31:591-606.e596. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.013.","journal-title":"Cancer Cell"},{"key":"2132_CR169","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/onc.2017.351","volume":"37","author":"A Visvanathan","year":"2018","unstructured":"Visvanathan A, et al. Essential role of METTL3-mediated m(6)A modification in glioma stem-like cells maintenance and radioresistance. Oncogene. 2018;37:522\u201333. https:\/\/doi.org\/10.1038\/onc.2017.351.","journal-title":"Oncogene"},{"key":"2132_CR170","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.freeradbiomed.2021.03.023","volume":"168","author":"L Ma","year":"2021","unstructured":"Ma L, et al. Targeting SLC3A2 subunit of system X(C)(-) is essential for m(6)A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Free Radical Biol Med. 2021;168:25\u201343. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.03.023.","journal-title":"Free Radical Biol Med"},{"key":"2132_CR171","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1111\/jcmm.16957","volume":"25","author":"Z Fan","year":"2021","unstructured":"Fan Z, et al. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. J Cell Mol Med. 2021;25:10197\u2013212. https:\/\/doi.org\/10.1111\/jcmm.16957.","journal-title":"J Cell Mol Med"},{"key":"2132_CR172","doi-asserted-by":"publisher","first-page":"e778","DOI":"10.1002\/ctm2.778","volume":"12","author":"L Liu","year":"2022","unstructured":"Liu L, et al. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma. Clin Transl Med. 2022;12:e778. https:\/\/doi.org\/10.1002\/ctm2.778.","journal-title":"Clin Transl Med"},{"key":"2132_CR173","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.1002\/tox.24272","volume":"39","author":"Z Huang","year":"2024","unstructured":"Huang Z, et al. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11. Environ Toxicol. 2024;39:4035\u201346. https:\/\/doi.org\/10.1002\/tox.24272.","journal-title":"Environ Toxicol"},{"key":"2132_CR174","doi-asserted-by":"publisher","first-page":"857765","DOI":"10.3389\/fendo.2022.857765","volume":"13","author":"FH Ji","year":"2022","unstructured":"Ji FH, Fu XH, Li GQ, He Q, Qiu XG. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner. Front Endocrinol. 2022;13:857765.\u00a0https:\/\/doi.org\/10.3389\/fendo.2022.857765.","journal-title":"Front Endocrinol"},{"key":"2132_CR175","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. Journal of experimental & clinical cancer research\u202f: CR. 2024;43:108. https:\/\/doi.org\/10.1186\/s13046-024-03032-9.","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"2132_CR176","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-022-04524-2","volume":"13","author":"S Sun","year":"2022","unstructured":"Sun S, et al. RNA binding protein NKAP protects glioblastoma cells from ferroptosis by promoting SLC7A11 mRNA splicing in an m(6)A-dependent manner. Cell Death Dis. 2022;13:73. https:\/\/doi.org\/10.1038\/s41419-022-04524-2.","journal-title":"Cell Death Dis"},{"key":"2132_CR177","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41467-022-30217-7","volume":"13","author":"Y Zou","year":"2022","unstructured":"Zou Y, et al. N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nat Commun. 2022;13:2672. https:\/\/doi.org\/10.1038\/s41467-022-30217-7.","journal-title":"Nat Commun"},{"key":"2132_CR178","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura T, et al. Phase separation of FSP1 promotes ferroptosis. Nature. 2023;619:371\u20137. https:\/\/doi.org\/10.1038\/s41586-023-06255-6.","journal-title":"Nature"},{"key":"2132_CR179","doi-asserted-by":"publisher","first-page":"119399","DOI":"10.1016\/j.lfs.2021.119399","volume":"276","author":"Z Song","year":"2021","unstructured":"Song Z, Jia G, Ma P, Cang S. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis. Life Sci. 2021;276:119399.\u00a0https:\/\/doi.org\/10.1016\/j.lfs.2021.119399.","journal-title":"Life Sci"},{"key":"2132_CR180","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1007\/s12094-022-03032-1","volume":"25","author":"C Bu","year":"2023","unstructured":"Bu C, et al. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability. Clinical & translational oncology\u202f: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 2023;25:1378\u201388. https:\/\/doi.org\/10.1007\/s12094-022-03032-1.","journal-title":"Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico"},{"key":"2132_CR181","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.7150\/ijbs.69141","volume":"18","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Neutrophil extracellular traps mediate m(6)A modification and regulates sepsis-associated acute lung injury by activating ferroptosis in alveolar epithelial cells. Int J Biol Sci. 2022;18:3337\u201357. https:\/\/doi.org\/10.7150\/ijbs.69141.","journal-title":"Int J Biol Sci"},{"key":"2132_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2022.10.065","volume":"638","author":"F Ye","year":"2023","unstructured":"Ye F, Wu J, Zhang F. METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis. Biochem Biophys Res Commun. 2023;638:1\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2022.10.065.","journal-title":"Biochem Biophys Res Commun"},{"key":"2132_CR183","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-024-01599-6","volume":"17","author":"J Wang","year":"2024","unstructured":"Wang J, Xiu M, Wang J, Gao Y, Li Y. METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. J Hematol Oncol. 2024;17:78. https:\/\/doi.org\/10.1186\/s13045-024-01599-6.","journal-title":"J Hematol Oncol"},{"key":"2132_CR184","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10495-023-01817-5","volume":"28","author":"K Wang","year":"2023","unstructured":"Wang K, et al. m6A writer WTAP targets NRF2 to accelerate bladder cancer malignancy via m6A-dependent ferroptosis regulation. Apoptosis\u202f: an international journal on programmed cell death. 2023;28:627\u201338. https:\/\/doi.org\/10.1007\/s10495-023-01817-5.","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"2132_CR185","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12967-021-03042-7","volume":"19","author":"L Feng","year":"2021","unstructured":"Feng L, et al. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis. J Transl Med. 2021;19:367. https:\/\/doi.org\/10.1186\/s12967-021-03042-7.","journal-title":"J Transl Med"},{"key":"2132_CR186","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 2019;23:101107.\u00a0https:\/\/doi.org\/10.1016\/j.redox.2019.101107.","journal-title":"Redox Biol"},{"key":"2132_CR187","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1158\/0008-5472.Can-22-4001","volume":"83","author":"K Chang","year":"2023","unstructured":"Chang K, et al. DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma. Can Res. 2023;83:3940\u201355. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-4001.","journal-title":"Can Res"},{"key":"2132_CR188","doi-asserted-by":"publisher","first-page":"100503","DOI":"10.1016\/j.mtbio.2022.100503","volume":"17","author":"X Xu","year":"2022","unstructured":"Xu X, et al. IGF2BP3 is an essential N(6)-methyladenosine biotarget for suppressing ferroptosis in lung adenocarcinoma cells. Materials today Bio. 2022;17:100503. https:\/\/doi.org\/10.1016\/j.mtbio.2022.100503.","journal-title":"Materials today Bio"},{"key":"2132_CR189","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.bbrc.2022.08.040","volume":"627","author":"Z Lu","year":"2022","unstructured":"Lu Z, et al. IGF2BP3-NRF2 axis regulates ferroptosis in hepatocellular carcinoma. Biochem Biophys Res Commun. 2022;627:103\u201310. https:\/\/doi.org\/10.1016\/j.bbrc.2022.08.040.","journal-title":"Biochem Biophys Res Commun"},{"key":"2132_CR190","doi-asserted-by":"publisher","first-page":"2349429","DOI":"10.1080\/15384047.2024.2349429","volume":"25","author":"L Li","year":"2024","unstructured":"Li L, Zeng J, He S, Yang Y, Wang C. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer. Cancer Biol Ther. 2024;25:2349429. https:\/\/doi.org\/10.1080\/15384047.2024.2349429.","journal-title":"Cancer Biol Ther"},{"key":"2132_CR191","doi-asserted-by":"publisher","first-page":"217004","DOI":"10.1016\/j.canlet.2024.217004","volume":"596","author":"Y Bian","year":"2024","unstructured":"Bian Y, et al. m(6)A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21\/IGF2BP2\/ FOXM1 positive feedback loop. Cancer Lett. 2024;596:217004. https:\/\/doi.org\/10.1016\/j.canlet.2024.217004.","journal-title":"Cancer Lett"},{"key":"2132_CR192","doi-asserted-by":"publisher","first-page":"103087","DOI":"10.1016\/j.redox.2024.103087","volume":"71","author":"H Li","year":"2024","unstructured":"Li H, et al. METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer. Redox Biol. 2024;71:103087. https:\/\/doi.org\/10.1016\/j.redox.2024.103087.","journal-title":"Redox Biol"},{"key":"2132_CR193","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/edbk_156572","volume":"35","author":"V Velcheti","year":"2016","unstructured":"Velcheti V, Schalper K. Basic Overview of Current Immunotherapy Approaches in Cancer. Am Soc Clin Oncol Educ Book. 2016;35:298\u2013308. https:\/\/doi.org\/10.1200\/edbk_156572.","journal-title":"Am Soc Clin Oncol Educ Book."},{"key":"2132_CR194","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jlb.3ma1220-815rrr","volume":"110","author":"R Kong","year":"2021","unstructured":"Kong R, Wang N, Han W, Bao W, Lu J. IFN\u03b3-mediated repression of system xc(-) drives vulnerability to induced ferroptosis in hepatocellular carcinoma cells. J Leukoc Biol. 2021;110:301\u201314. https:\/\/doi.org\/10.1002\/jlb.3ma1220-815rrr.","journal-title":"J Leukoc Biol"},{"key":"2132_CR195","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao P, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell. 2022;40:365-378.e366. https:\/\/doi.org\/10.1016\/j.ccell.2022.02.003.","journal-title":"Cancer Cell"},{"key":"2132_CR196","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35:84-100.e108. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021.","journal-title":"Cell Metab"},{"key":"2132_CR197","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.molcel.2023.05.011","volume":"83","author":"Y Han","year":"2023","unstructured":"Han Y, et al. IL-1\u03b2-associated NNT acetylation orchestrates iron-sulfur cluster maintenance and cancer immunotherapy resistance. Mol Cell. 2023;83:1887-1902.e1888. https:\/\/doi.org\/10.1016\/j.molcel.2023.05.011.","journal-title":"Mol Cell"},{"key":"2132_CR198","doi-asserted-by":"publisher","first-page":"e2204514","DOI":"10.1002\/advs.202204514","volume":"10","author":"CH Chung","year":"2023","unstructured":"Chung CH, et al. Ferroptosis signature shapes the immune profiles to enhance the response to immune checkpoint inhibitors in head and neck cancer. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2023;10:e2204514. https:\/\/doi.org\/10.1002\/advs.202204514.","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"2132_CR199","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s41419-020-03140-2","volume":"11","author":"Q Gou","year":"2020","unstructured":"Gou Q, et al. PD-L1 degradation pathway and immunotherapy for cancer. Cell Death Dis. 2020;11:955. https:\/\/doi.org\/10.1038\/s41419-020-03140-2.","journal-title":"Cell Death Dis"},{"key":"2132_CR200","doi-asserted-by":"publisher","first-page":"102350","DOI":"10.1016\/j.ctrv.2022.102350","volume":"104","author":"A Friedlaender","year":"2022","unstructured":"Friedlaender A, et al. Role and impact of immune checkpoint inhibitors in neoadjuvant treatment for NSCLC. Cancer Treat Rev. 2022;104:102350.","journal-title":"Cancer Treat Rev"},{"key":"2132_CR201","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2174\/1568009622666220301145013","volume":"22","author":"Z Zhou","year":"2022","unstructured":"Zhou Z, et al. Systematic analysis of the expression profile and prognostic significance of the IGF2BP family in lung adenocarcinoma. Curr Cancer Drug Targets. 2022;22:340\u201350. https:\/\/doi.org\/10.2174\/1568009622666220301145013.","journal-title":"Curr Cancer Drug Targets"},{"key":"2132_CR202","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20:105. https:\/\/doi.org\/10.1186\/s12943-021-01398-4.","journal-title":"Mol Cancer"},{"key":"2132_CR203","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21:60. https:\/\/doi.org\/10.1186\/s12943-021-01447-y.","journal-title":"Mol Cancer"},{"key":"2132_CR204","doi-asserted-by":"publisher","first-page":"e104514","DOI":"10.15252\/embj.2020104514","volume":"39","author":"L Wang","year":"2020","unstructured":"Wang L, et al. m(6) A RNA methyltransferases METTL3\/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020;39:e104514. https:\/\/doi.org\/10.15252\/embj.2020104514.","journal-title":"EMBO J"},{"key":"2132_CR205","doi-asserted-by":"publisher","first-page":"845193","DOI":"10.3389\/fimmu.2022.845193","volume":"13","author":"H Zheng","year":"2022","unstructured":"Zheng H, et al. Decreased Expression of Programmed Death Ligand-L1 by Seven in Absentia Homolog 2 in Cholangiocarcinoma Enhances T-Cell-Mediated Antitumor Activity. Front Immunol. 2022;13:845193.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2022.845193.","journal-title":"Front Immunol"},{"key":"2132_CR206","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10565-022-09718-0","volume":"38","author":"L Peng","year":"2022","unstructured":"Peng L, et al. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Cell Biol Toxicol. 2022;38:1159\u201373. https:\/\/doi.org\/10.1007\/s10565-022-09718-0.","journal-title":"Cell Biol Toxicol"},{"key":"2132_CR207","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Su R, Deng X, Chen Y, Chen J. FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends in cancer. 2022;8:598\u2013614. https:\/\/doi.org\/10.1016\/j.trecan.2022.02.010.","journal-title":"Trends in cancer"},{"key":"2132_CR208","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","volume":"38","author":"R Su","year":"2020","unstructured":"Su R, et al. Targeting FTO suppresses cancer stem cell maintenance and immune evasion. Cancer Cell. 2020;38:79-96.e11. https:\/\/doi.org\/10.1016\/j.ccell.2020.04.017.","journal-title":"Cancer Cell"},{"key":"2132_CR209","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1158\/0008-5472.Can-21-0468","volume":"81","author":"X Qiu","year":"2021","unstructured":"Qiu X, et al. M(6)A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma. Can Res. 2021;81:4778\u201393. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0468.","journal-title":"Can Res"},{"key":"2132_CR210","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1158\/0008-5472.Can-21-1456","volume":"81","author":"F Dong","year":"2021","unstructured":"Dong F, et al. ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment. Can Res. 2021;81:5876\u201388. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1456.","journal-title":"Can Res"},{"key":"2132_CR211","doi-asserted-by":"publisher","first-page":"20159","DOI":"10.1073\/pnas.1918986117","volume":"117","author":"N Li","year":"2020","unstructured":"Li N, et al. ALKBH5 regulates anti-PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment. Proc Natl Acad Sci USA. 2020;117:20159\u201370. https:\/\/doi.org\/10.1073\/pnas.1918986117.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2132_CR212","doi-asserted-by":"publisher","first-page":"789914","DOI":"10.3389\/fimmu.2021.789914","volume":"12","author":"A Du","year":"2021","unstructured":"Du A, et al. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia. Front Immunol. 2021;12:789914. https:\/\/doi.org\/10.3389\/fimmu.2021.789914.","journal-title":"Front Immunol"},{"key":"2132_CR213","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/cam4.4531","volume":"11","author":"S Han","year":"2022","unstructured":"Han S, et al. Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in acute myeloid leukemia. Cancer Med. 2022;11:1413\u201326. https:\/\/doi.org\/10.1002\/cam4.4531.","journal-title":"Cancer Med"},{"key":"2132_CR214","doi-asserted-by":"publisher","first-page":"902","DOI":"10.21037\/atm-22-385","volume":"10","author":"S Yuan","year":"2022","unstructured":"Yuan S, et al. Analysis of m6A-related signatures associated with the tumor immune microenvironment and predict survival in acute myeloid leukemia. Ann Transl Med. 2022;10:902. https:\/\/doi.org\/10.21037\/atm-22-385.","journal-title":"Ann Transl Med."},{"key":"2132_CR215","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1007\/s00432-023-05029-x","volume":"149","author":"J Yang","year":"2023","unstructured":"Yang J, et al. The m6A modulator-mediated cytarabine sensitivity and immune cell infiltration signature in acute myeloid leukemia. J Cancer Res Clin Oncol. 2023;149:11457\u201369. https:\/\/doi.org\/10.1007\/s00432-023-05029-x.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2132_CR216","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1158\/0008-5472.Can-18-2965","volume":"79","author":"Q Lan","year":"2019","unstructured":"Lan Q, et al. The Critical Role of RNA m(6)A Methylation in Cancer. Can Res. 2019;79:1285\u201392. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-2965.","journal-title":"Can Res"},{"key":"2132_CR217","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc.2015.5","volume":"16","author":"MG Morvan","year":"2016","unstructured":"Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016;16:7\u201319. https:\/\/doi.org\/10.1038\/nrc.2015.5.","journal-title":"Nat Rev Cancer"},{"key":"2132_CR218","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/30989","volume":"393","author":"JP Ridge","year":"1998","unstructured":"Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998;393:474\u20138. https:\/\/doi.org\/10.1038\/30989.","journal-title":"Nature"},{"key":"2132_CR219","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol. 2012;12:557\u201369. https:\/\/doi.org\/10.1038\/nri3254.","journal-title":"Nat Rev Immunol"},{"key":"2132_CR220","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1038\/s41467-019-09903-6","volume":"10","author":"H Wang","year":"2019","unstructured":"Wang H, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10:1898. https:\/\/doi.org\/10.1038\/s41467-019-09903-6.","journal-title":"Nat Commun"},{"key":"2132_CR221","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-0916-x","volume":"566","author":"D Han","year":"2019","unstructured":"Han D, et al. Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 2019;566:270\u20134. https:\/\/doi.org\/10.1038\/s41586-019-0916-x.","journal-title":"Nature"},{"key":"2132_CR222","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng K, et al. Tumor-associated macrophages in liver cancer: from mechanisms to therapy. Cancer Comm (London, England). 2022;42:1112\u201340. https:\/\/doi.org\/10.1002\/cac2.12345.","journal-title":"Cancer Comm (London, England)"},{"key":"2132_CR223","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1158\/0008-5472.Can-16-2631","volume":"76","author":"C Caux","year":"2016","unstructured":"Caux C, Ramos RN, Prendergast GC, Bendriss-Vermare N, M\u00e9n\u00e9trier-Caux C. A milestone review on how macrophages affect tumor growth. Can Res. 2016;76:6439\u201342. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2631.","journal-title":"Can Res"},{"key":"2132_CR224","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12:1394. https:\/\/doi.org\/10.1038\/s41467-021-21514-8.","journal-title":"Nat Commun"},{"issue":"18","key":"2132_CR225","doi-asserted-by":"publisher","first-page":"eabd4742","DOI":"10.1126\/sciadv.abd4742","volume":"7","author":"J Tong","year":"2021","unstructured":"Tong J, et al. Pooled CRISPR screening identifies m(6)A as a positive regulator of macrophage activation. Sci Adv. 2021;7(18):eabd4742. https:\/\/doi.org\/10.1126\/sciadv.abd4742.","journal-title":"Sci Adv."},{"issue":"6","key":"2132_CR226","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3390\/ijms20061323","volume":"20","author":"R Yu","year":"2019","unstructured":"Yu R, Li Q, Feng Z, Cai L, Xu Q. m6A Reader YTHDF2 Regulates LPS-Induced inflammatory response. Int J Mol Sci. 2019;20(6):1323. https:\/\/doi.org\/10.3390\/ijms20061323.","journal-title":"Int J Mol Sci."},{"key":"2132_CR227","doi-asserted-by":"publisher","first-page":"5001","DOI":"10.7150\/ijbs.70149","volume":"18","author":"Y You","year":"2022","unstructured":"You Y, et al. ALKBH5\/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression. Int J Biol Sci. 2022;18:5001\u201318. https:\/\/doi.org\/10.7150\/ijbs.70149.","journal-title":"Int J Biol Sci"},{"key":"2132_CR228","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.it.2019.06.002","volume":"40","author":"SL Park","year":"2019","unstructured":"Park SL, Gebhardt T, Mackay LK. Tissue-Resident Memory T Cells in Cancer Immunosurveillance. Trends Immunol. 2019;40:735\u201347. https:\/\/doi.org\/10.1016\/j.it.2019.06.002.","journal-title":"Trends Immunol"},{"key":"2132_CR229","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri798","volume":"2","author":"RN Germain","year":"2002","unstructured":"Germain RN. T-cell development and the CD4-CD8 lineage decision. Nat Rev Immunol. 2002;2:309\u201322. https:\/\/doi.org\/10.1038\/nri798.","journal-title":"Nat Rev Immunol"},{"key":"2132_CR230","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature23450","volume":"548","author":"HB Li","year":"2017","unstructured":"Li HB, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7\/STAT5\/SOCS pathways. Nature. 2017;548:338\u201342. https:\/\/doi.org\/10.1038\/nature23450.","journal-title":"Nature"},{"key":"2132_CR231","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/cr.2018.7","volume":"28","author":"J Tong","year":"2018","unstructured":"Tong J, et al. m(6)A mRNA methylation sustains Treg suppressive functions. Cell Res. 2018;28:253\u20136. https:\/\/doi.org\/10.1038\/cr.2018.7.","journal-title":"Cell Res"},{"key":"2132_CR232","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10142-024-01292-4","volume":"24","author":"D Jin","year":"2024","unstructured":"Jin D, et al. LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruiting IGF2BP3\/SLC7A11 in hepatocellular carcinoma. Funct Integr Genomics. 2024;24:29. https:\/\/doi.org\/10.1007\/s10142-024-01292-4.","journal-title":"Funct Integr Genomics"},{"key":"2132_CR233","doi-asserted-by":"publisher","first-page":"e1829","DOI":"10.1002\/wrna.1829","volume":"15","author":"J Gu","year":"2024","unstructured":"Gu J, et al. RNA m6A modifications regulate crosstalk between tumor metabolism and immunity. Wiley interdisciplinary reviews RNA. 2024;15:e1829.\u00a0https:\/\/doi.org\/10.1002\/wrna.1829.","journal-title":"Wiley interdisciplinary reviews RNA"},{"key":"2132_CR234","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2147\/dddt.S291865","volume":"15","author":"W Xu","year":"2021","unstructured":"Xu W, et al. Effects of quercetin on the efficacy of various chemotherapeutic drugs in cervical cancer cells. Drug Des Dev Ther. 2021;15:577\u201388. https:\/\/doi.org\/10.2147\/dddt.S291865.","journal-title":"Drug Des Dev Ther"},{"key":"2132_CR235","doi-asserted-by":"publisher","first-page":"901","DOI":"10.18632\/oncotarget.22868","volume":"9","author":"W Lai","year":"2018","unstructured":"Lai W, et al. Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing. Oncotarget. 2018;9:901\u201314. https:\/\/doi.org\/10.18632\/oncotarget.22868.","journal-title":"Oncotarget."},{"key":"2132_CR236","doi-asserted-by":"publisher","first-page":"4039","DOI":"10.1128\/aem.62.11.4039-4043.1996","volume":"62","author":"CW Bacon","year":"1996","unstructured":"Bacon CW, Porter JK, Norred WP, Leslie JF. Production of fusaric acid by Fusarium species. Appl Environ Microbiol. 1996;62:4039\u201343. https:\/\/doi.org\/10.1128\/aem.62.11.4039-4043.1996.","journal-title":"Appl Environ Microbiol"},{"key":"2132_CR237","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/15592294.2020.1788324","volume":"16","author":"T Ghazi","year":"2021","unstructured":"Ghazi T, Nagiah S, Chuturgoon AA. Fusaric acid decreases p53 expression by altering promoter methylation and m6A RNA methylation in human hepatocellular carcinoma (HepG2) cells. Epigenetics. 2021;16:79\u201391. https:\/\/doi.org\/10.1080\/15592294.2020.1788324.","journal-title":"Epigenetics"},{"key":"2132_CR238","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ymben.2017.06.005","volume":"42","author":"X Huang","year":"2017","unstructured":"Huang X, Liang Y, Yang Y, Lu X. Single-step production of the simvastatin precursor monacolin J by engineering of an industrial strain of Aspergillus terreus. Metab Eng. 2017;42:109\u201314. https:\/\/doi.org\/10.1016\/j.ymben.2017.06.005.","journal-title":"Metab Eng"},{"key":"2132_CR239","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.26355\/eurrev_202004_21006","volume":"24","author":"WW Chen","year":"2020","unstructured":"Chen WW, et al. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA. Eur Rev Med Pharmacol Sci. 2020;24:4263\u201370. https:\/\/doi.org\/10.26355\/eurrev_202004_21006.","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"2132_CR240","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601. https:\/\/doi.org\/10.1038\/s41586-021-03536-w.","journal-title":"Nature"},{"key":"2132_CR241","doi-asserted-by":"publisher","first-page":"12738","DOI":"10.1021\/acs.jmedchem.1c00773","volume":"64","author":"A Dolbois","year":"2021","unstructured":"Dolbois A, et al. Derivatives as potent and selective METTL3 inhibitors1,4,9-Triazaspiro[5.5]undecan-2-one derivatives as potent and selective METTL3 inhibitors. J Med Chemistry. 2021;64:12738\u201360. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00773.","journal-title":"J Med Chemistry."},{"key":"2132_CR242","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/ddr.21910","volume":"83","author":"JH Lee","year":"2022","unstructured":"Lee JH, Kim S, Jin MS, Kim YC. Discovery of substituted indole derivatives as allosteric inhibitors of m(6) A-RNA methyltransferase, METTL3-14 complex. Drug Dev Res. 2022;83:783\u201399. https:\/\/doi.org\/10.1002\/ddr.21910.","journal-title":"Drug Dev Res"},{"issue":"4","key":"2132_CR243","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/ph15040440","volume":"15","author":"JH Lee","year":"2022","unstructured":"Lee JH, et al. Eltrombopag as an allosteric inhibitor of the METTL3\u201314 complex affecting the m(6)A methylation of RNA in acute myeloid leukemia cells. Pharmaceuticals (Basel, Switzerland). 2022;15(4):440. https:\/\/doi.org\/10.3390\/ph15040440.","journal-title":"Pharmaceuticals (Basel, Switzerland)."},{"key":"2132_CR244","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, et al. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23:850\u20138. https:\/\/doi.org\/10.1038\/nm.4345.","journal-title":"Nat Med"},{"key":"2132_CR245","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41389-020-00290-y","volume":"10","author":"L Cheng","year":"2021","unstructured":"Cheng L, et al. Metformin exhibits antiproliferation activity in breast cancer via miR-483-3p\/METTL3\/m(6)A\/p21 pathway. Oncogenesis. 2021;10:7. https:\/\/doi.org\/10.1038\/s41389-020-00290-y.","journal-title":"Oncogenesis"},{"key":"2132_CR246","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.phymed.2018.09.174","volume":"50","author":"X Li","year":"2018","unstructured":"Li X, Li X, Huang N, Liu R, Sun R. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine\u202f: Int J Phytother Phytopharmacol. 2018;50:73\u201387. https:\/\/doi.org\/10.1016\/j.phymed.2018.09.174.","journal-title":"Phytomedicine : Int J Phytother Phytopharmacol"},{"key":"2132_CR247","doi-asserted-by":"publisher","first-page":"5831","DOI":"10.7150\/thno.55574","volume":"11","author":"K Sun","year":"2021","unstructured":"Sun K, et al. Saikosaponin D exhibits anti-leukemic activity by targeting FTO\/m(6)A signaling. Theranostics. 2021;11:5831\u201346. https:\/\/doi.org\/10.7150\/thno.55574.","journal-title":"Theranostics"},{"key":"2132_CR248","doi-asserted-by":"publisher","first-page":"13310","DOI":"10.1021\/acsomega.1c01289","volume":"6","author":"S Selberg","year":"2021","unstructured":"Selberg S, Seli N, Kankuri E, Karelson M. Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors. ACS Omega. 2021;6:13310\u201320. https:\/\/doi.org\/10.1021\/acsomega.1c01289.","journal-title":"ACS Omega"},{"key":"2132_CR249","doi-asserted-by":"publisher","first-page":"15944","DOI":"10.1021\/acs.jmedchem.3c01374","volume":"66","author":"YZ Wang","year":"2023","unstructured":"Wang YZ, et al. Discovery of pyrazolo[1,5-a]pyrimidine derivative as a novel and selective ALKBH5 inhibitor for the treatment of AML. J Med Chem. 2023;66:15944\u201359. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01374.","journal-title":"J Med Chem"},{"key":"2132_CR250","doi-asserted-by":"publisher","first-page":"115300","DOI":"10.1016\/j.bmc.2019.115300","volume":"28","author":"A Malacrida","year":"2020","unstructured":"Malacrida A, et al. 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line. Bioorg Med Chem. 2020;28:115300.\u00a0https:\/\/doi.org\/10.1016\/j.bmc.2019.115300.","journal-title":"Bioorg Med Chem"},{"key":"2132_CR251","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1021\/cn500042t","volume":"5","author":"G Zheng","year":"2014","unstructured":"Zheng G, et al. Synthesis of a FTO inhibitor with anticonvulsant activity. ACS Chem Neurosci. 2014;5:658\u201365. https:\/\/doi.org\/10.1021\/cn500042t.","journal-title":"ACS Chem Neurosci"},{"key":"2132_CR252","doi-asserted-by":"publisher","first-page":"e0159072","DOI":"10.1371\/journal.pone.0159072","volume":"11","author":"B Singh","year":"2016","unstructured":"Singh B, et al. Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge. PLoS ONE. 2016;11:e0159072.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0159072.","journal-title":"PLoS ONE"},{"key":"2132_CR253","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1038\/onc.2015.466","volume":"35","author":"R Bharti","year":"2016","unstructured":"Bharti R, et al. Diacerein-mediated inhibition of IL-6\/IL-6R signaling induces apoptotic effects on breast cancer. Oncogene. 2016;35:3965\u201375. https:\/\/doi.org\/10.1038\/onc.2015.466.","journal-title":"Oncogene"},{"key":"2132_CR254","doi-asserted-by":"publisher","first-page":"13936","DOI":"10.1021\/acs.analchem.0c02828","volume":"92","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Li QN, Zhou K, Xu Q, Zhang CY. Identification of Specific N(6)-Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors. Anal Chem. 2020;92:13936\u201344. https:\/\/doi.org\/10.1021\/acs.analchem.0c02828.","journal-title":"Anal Chem"},{"key":"2132_CR255","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.apsb.2021.08.028","volume":"12","author":"G Xie","year":"2022","unstructured":"Xie G, et al. A novel inhibitor of N (6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities. Acta pharmaceutica Sinica B. 2022;12:853\u201366. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.028.","journal-title":"Acta pharmaceutica Sinica B"},{"key":"2132_CR256","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/nar\/gku1276","volume":"43","author":"Y Huang","year":"2015","unstructured":"Huang Y, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015;43:373\u201384. https:\/\/doi.org\/10.1093\/nar\/gku1276.","journal-title":"Nucleic Acids Res"},{"key":"2132_CR257","doi-asserted-by":"publisher","first-page":"870636","DOI":"10.3389\/fonc.2022.870636","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen H, Jia B, Zhang Q, Zhang Y. Meclofenamic acid restores gefinitib sensitivity by downregulating breast cancer resistance protein and multidrug resistance protein 7 via FTO\/m6A-demethylation\/c-Myc in non-small cell lung cancer. Front Oncol. 2022;12:870636. https:\/\/doi.org\/10.3389\/fonc.2022.870636.","journal-title":"Front Oncol"},{"key":"2132_CR258","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","volume":"35","author":"Y Huang","year":"2019","unstructured":"Huang Y, et al. Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia. Cancer Cell. 2019;35:677-691.e610. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.006.","journal-title":"Cancer Cell"},{"key":"2132_CR259","doi-asserted-by":"publisher","first-page":"9731","DOI":"10.1021\/acs.jmedchem.3c00543","volume":"66","author":"P Xiao","year":"2023","unstructured":"Xiao P, et al. Rational design of RNA demethylase FTO inhibitors with enhanced antileukemia drug-like properties. J Med Chem. 2023;66:9731\u201352. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c00543.","journal-title":"J Med Chem"},{"key":"2132_CR260","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.cmet.2021.04.001","volume":"33","author":"Y Liu","year":"2021","unstructured":"Liu Y, et al. Tumors exploit FTO-mediated regulation of glycolytic metabolism to evade immune surveillance. Cell Metab. 2021;33:1221-1233.e1211. https:\/\/doi.org\/10.1016\/j.cmet.2021.04.001.","journal-title":"Cell Metab"},{"key":"2132_CR261","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1021\/acschembio.0c00841","volume":"16","author":"S Huff","year":"2021","unstructured":"Huff S, Tiwari SK, Gonzalez GM, Wang Y, Rana TM. m(6)A-RNA demethylase FTO inhibitors impair self-renewal in glioblastoma stem cells. ACS Chem Biol. 2021;16:324\u201333. https:\/\/doi.org\/10.1021\/acschembio.0c00841.","journal-title":"ACS Chem Biol"},{"key":"2132_CR262","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.jmedchem.1c02075","volume":"65","author":"S Huff","year":"2022","unstructured":"Huff S, et al. Rational design and optimization of m(6)A-RNA demethylase FTO inhibitors as anticancer agents. J Med Chem. 2022;65:10920\u201337. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c02075.","journal-title":"J Med Chem"},{"key":"2132_CR263","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41388-022-02214-z","volume":"41","author":"D Lv","year":"2022","unstructured":"Lv D, et al. M(6)A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression. Oncogene. 2022;41:1727\u201341. https:\/\/doi.org\/10.1038\/s41388-022-02214-z.","journal-title":"Oncogene"},{"key":"2132_CR264","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. Allosteric regulation of IGF2BP1 as a novel strategy for the activation of tumor immune microenvironment. ACS Cent Sci. 2022;8:1102\u201315. https:\/\/doi.org\/10.1021\/acscentsci.2c00107.","journal-title":"ACS Cent Sci"},{"key":"2132_CR265","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/0008-5472.Can-21-4249","volume":"83","author":"YG Hong","year":"2023","unstructured":"Hong YG, et al. The RNA m6A reader YTHDF1 is required for acute myeloid leukemia progression. Can Res. 2023;83:845\u201360. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-4249.","journal-title":"Can Res"},{"key":"2132_CR266","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","volume":"41","author":"L Wang","year":"2023","unstructured":"Wang L, et al. YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023;41:1294-1308.e1298. https:\/\/doi.org\/10.1016\/j.ccell.2023.04.019.","journal-title":"Cancer Cell"},{"key":"2132_CR267","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1038\/s41375-022-01651-9","volume":"36","author":"P Feng","year":"2022","unstructured":"Feng P, et al. Inhibition of the m(6)A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia. Leukemia. 2022;36:2180\u20138. https:\/\/doi.org\/10.1038\/s41375-022-01651-9.","journal-title":"Leukemia"},{"key":"2132_CR268","unstructured":"Synapse. STORM therapeutics presented interim Phase 1 data on STC-15 at ASCO. 2024. https:\/\/synapse.patsnap.com\/article\/storm-therapeutics-presented-interim-phase-1-data-on-stc-15-at-asco-2024."},{"key":"2132_CR269","unstructured":"Oncology, R. Expanded heart protection discovery for Zantrene. 2021. https:\/\/raceoncology.com\/expanded-heart-protection-discovery-for-zantrene\/."},{"key":"2132_CR270","unstructured":"Wikipedia. Bisantrene. 2021.\u00a0https:\/\/en.wikipedia.org\/wiki\/Bisantrene."},{"key":"2132_CR271","unstructured":"Drugs.com. Entacapone side effects. 2024.\u00a0https:\/\/www.drugs.com\/sfx\/entacapone-side-effects.html."},{"key":"2132_CR272","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","volume":"29","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jin P, Wang X. N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner. Apoptosis\u202f: Int J Programmed Cell Death. 2024;29:142\u201353. https:\/\/doi.org\/10.1007\/s10495-023-01885-7.","journal-title":"Apoptosis : Int J Programmed Cell Death"},{"key":"2132_CR273","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nature24637","volume":"551","author":"SW Alvarez","year":"2017","unstructured":"Alvarez SW, et al. NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature. 2017;551:639\u201343. https:\/\/doi.org\/10.1038\/nature24637.","journal-title":"Nature"},{"key":"2132_CR274","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nm.4232","volume":"23","author":"SL Cramer","year":"2017","unstructured":"Cramer SL, et al. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat Med. 2017;23:120\u20137. https:\/\/doi.org\/10.1038\/nm.4232.","journal-title":"Nat Med"},{"key":"2132_CR275","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s12943-020-01157-x","volume":"19","author":"Y Wu","year":"2020","unstructured":"Wu Y, et al. The epigenetic regulators and metabolic changes in ferroptosis-associated cancer progression. Mol Cancer. 2020;19:39. https:\/\/doi.org\/10.1186\/s12943-020-01157-x.","journal-title":"Mol Cancer"},{"key":"2132_CR276","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12943-024-02041-8","volume":"23","author":"Y Li","year":"2024","unstructured":"Li Y, et al. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Mol Cancer. 2024;23:130. https:\/\/doi.org\/10.1186\/s12943-024-02041-8.","journal-title":"Mol Cancer"},{"key":"2132_CR277","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-024-01777-5","volume":"9","author":"WW Liu","year":"2024","unstructured":"Liu WW, et al. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy. Signal Transduct Target Ther. 2024;9:70. https:\/\/doi.org\/10.1038\/s41392-024-01777-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2132_CR278","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13045-024-01546-5","volume":"17","author":"G Feng","year":"2024","unstructured":"Feng G, et al. Small molecule inhibitors targeting m(6)A regulators. J Hematol Oncol. 2024;17:30. https:\/\/doi.org\/10.1186\/s13045-024-01546-5.","journal-title":"J Hematol Oncol"},{"key":"2132_CR279","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-022-01510-2","volume":"21","author":"LJ Deng","year":"2022","unstructured":"Deng LJ, et al. m6A modification: recent advances, anticancer targeted drug discovery and beyond. Mol Cancer. 2022;21:52. https:\/\/doi.org\/10.1186\/s12943-022-01510-2.","journal-title":"Mol Cancer"}],"updated-by":[{"DOI":"10.1186\/s12943-024-02144-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000}}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-024-02132-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-024-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:05:56Z","timestamp":1728367556000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-024-02132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":279,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1186\/s12943-024-02132-6","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12943-024-02144-2","asserted-by":"object"}]},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"25 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Following publication of the original article [1], the authors noticed that the Funding information was not indicated in the article. The details of Funding were included in the revised manuscript that was submitted by the author to production system. The Funding information is given in the article correction \"10.1186\/s12943-024-02144-2\".","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12943-024-02144-2","URL":"https:\/\/doi.org\/10.1186\/s12943-024-02144-2","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved to publish this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"213"}}